Home LiteratureArticle Details
PMID: 11250893 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.

The EMBO journal ·Vol. 20 ·No. 6 ·2001-03-15 ·Pages 1271-80

Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, Inoue J

Abstract

Signals emanating from the receptor for interleukin-1 (IL-1), lipopolysaccharide (LPS) or osteoclast differentiation factor/receptor activator of NF kappa B ligand (ODF/RANKL) stimulate transcription factors AP-1 through mitogen-activated protein kinase (MAPK) activation and NF kappa B through I kappa B kinase (IKK) activation. These kinases are thought to be activated by tumor necrosis factor receptor-associated factor 6 (TRAF6). However, molecular mechanisms by which TRAF6 activates various downstream kinases remain to be elucidated. We identified functional domains of TRAF6 under physiological conditions established by appropriate expression of TRAF6 mutants in TRAF6-deficient cells. In IL-1 and LPS signaling pathways, the RING finger and first zinc finger domains are not required for NF kappa B activation but are required for full activation of MAPK. However, IL-1 and LPS signals utilize distinct regions within the zinc finger domains of TRAF6 to activate NF kappa B. Furthermore, the RING finger domain is not required for differentiation of splenocytes to multinuclear osteoclasts, but is essential for osteoclast maturation. Thus, TRAF6 plays essential roles in both the differentiation and maturation of osteoclasts by activating various kinases via its multiple domains.

MeSH Terms
Animals Binding Sites Bone Resorption/metabolism Cell Differentiation Enzyme Activation Interleukin-1/pharmacology JNK Mitogen-Activated Protein Kinases Lipopolysaccharides/pharmacology Mice Mice, Mutant Strains Mitogen-Activated Protein Kinases/metabolism NF-kappa B/metabolism Osteoclasts/cytology,metabolism Protein Binding Protein Structure, Tertiary Proteins/genetics,metabolism Signal Transduction TNF Receptor-Associated Factor 2 TNF Receptor-Associated Factor 5 TNF Receptor-Associated Factor 6 Zinc Fingers p38 Mitogen-Activated Protein Kinases
Chemicals
Interleukin-1 Lipopolysaccharides NF-kappa B Proteins TNF Receptor-Associated Factor 2 TNF Receptor-Associated Factor 5 TNF Receptor-Associated Factor 6 JNK Mitogen-Activated Protein Kinases Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Kobayashi N
Department of Hematology, Research Institute, International Medical Center of Japan, Shinjuku-ku, Tokyo 162-8655, Japan.
Kadono Y
Naito A
Matsumoto K
Yamamoto T
Tanaka S
Inoue J
References (43)
43 references, click to expand
  1. Requirement for NF-kappaB in osteoclast and B-cell development.
    Genes Dev. 1997 Dec 15;11(24):3482-96 PMID: 9407039
  2. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
    Cell. 2000 Oct 13;103(2):351-61 PMID: 11057907
  3. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.
    Immunity. 1998 Jul;9(1):143-50 PMID: 9697844
  4. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    J Clin Invest. 1998 Sep 1;102(5):881-92 PMID: 9727056
  5. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling.
    J Biol Chem. 1998 Sep 18;273(38):24775-80 PMID: 9733779
  6. Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death.
    Genes Dev. 1998 Sep 15;12(18):2821-30 PMID: 9744859
  7. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    J Biol Chem. 1998 Oct 23;273(43):28355-9 PMID: 9774460
  8. ASK1 is essential for JNK/SAPK activation by TRAF2.
    Mol Cell. 1998 Sep;2(3):389-95 PMID: 9774977
  9. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    J Biol Chem. 1998 Dec 18;273(51):34120-7 PMID: 9852070
  10. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  11. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts.
    Proc Natl Acad Sci U S A. 1993 May 15;90(10):4485-9 PMID: 7685105
  12. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.
    Cell. 1994 Aug 26;78(4):681-92 PMID: 8069916
  13. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.
    Science. 1994 Oct 21;266(5184):443-8 PMID: 7939685
  14. Involvement of CRAF1, a relative of TRAF, in CD40 signaling.
    Science. 1995 Mar 10;267(5203):1494-8 PMID: 7533327
  15. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.
    J Biol Chem. 1996 Jun 21;271(25):14661-4 PMID: 8663299
  16. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
    J Biol Chem. 1996 Aug 16;271(33):19935-42 PMID: 8702708
  17. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
    Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9437-42 PMID: 8790348
  18. TRAF6 is a signal transducer for interleukin-1.
    Nature. 1996 Oct 3;383(6599):443-6 PMID: 8837778
  19. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.
    Nature. 1996 Oct 10;383(6600):528-31 PMID: 8849724
  20. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
    J Biol Chem. 1996 Nov 15;271(46):28745-8 PMID: 8910514
  21. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.
    Genes Dev. 1997 Nov 1;11(21):2835-44 PMID: 9353253
  22. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.
    Nat Med. 1997 Nov;3(11):1285-9 PMID: 9359707
  23. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.
    Immunity. 1997 Nov;7(5):715-25 PMID: 9390694
  24. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
    Science. 1998 Dec 11;282(5396):2085-8 PMID: 9851930
  25. Association of the p75 neurotrophin receptor with TRAF6.
    J Biol Chem. 1999 Jan 29;274(5):2597-600 PMID: 9915784
  26. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
    Nature. 1999 Jan 28;397(6717):315-23 PMID: 9950424
  27. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
    Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1234-9 PMID: 9990007
  28. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Nature. 1999 Mar 18;398(6724):252-6 PMID: 10094049
  29. Structural basis for self-association and receptor recognition of human TRAF2.
    Nature. 1999 Apr 8;398(6727):533-8 PMID: 10206649
  30. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
    Genes Dev. 1999 Apr 15;13(8):1015-24 PMID: 10215628
  31. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain.
    Genes Dev. 1999 May 15;13(10):1297-308 PMID: 10346818
  32. Crystallographic analysis of CD40 recognition and signaling by human TRAF2.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8408-13 PMID: 10411888
  33. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice.
    Genes Cells. 1999 Jun;4(6):353-62 PMID: 10421844
  34. Unresponsiveness of MyD88-deficient mice to endotoxin.
    Immunity. 1999 Jul;11(1):115-22 PMID: 10435584
  35. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9803-8 PMID: 10449775
  36. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.
    Genes Dev. 1999 Aug 15;13(16):2059-71 PMID: 10465784
  37. RANK is essential for osteoclast and lymph node development.
    Genes Dev. 1999 Sep 15;13(18):2412-24 PMID: 10500098
  38. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.
    Mol Cell. 1999 Dec;4(6):1041-9 PMID: 10635328
  39. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
    Nat Genet. 2000 Feb;24(2):184-7 PMID: 10655067
  40. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
    J Clin Invest. 2000 Feb;105(4):433-40 PMID: 10683372
  41. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.
    Mol Cell. 2000 Apr;5(4):649-58 PMID: 10882101
  42. Bone resorption by osteoclasts.
    Science. 2000 Sep 1;289(5484):1504-8 PMID: 10968780
  43. New experimental approaches in retrovirus-mediated expression screening.
    Int J Hematol. 1998 Jun;67(4):351-9 PMID: 9695408
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2001-03-15
Pages
1271-80
Language
English
Region
England
NLM ID
8208664
PMCID
PMC145527
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]